Which Factors Will Push The IVD Raw Materials Market To Achieve $39.88 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The IVD Raw Materials Market?
The market size for ivd raw materials has notably expanded in the past few years. It is projected to progress from $25.13 billion in 2024 to $27.47 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.3%. The historic growth has been driven by factors such as augmenting instances of infectious and chronic diseases, an escalated demand for lab-based diagnostic testing, a surge in the use of enzyme and protein-based reagents for diagnostics, the expansion of clinical diagnostic labs, and an increase in awareness and initiatives for early disease detection.
Expectations for the ivd raw materials market project a robust expansion in the upcoming years with a projected value of $39.88 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.8%. This significant increase is due largely to factors such as a surge in demand for rapid and highly sensitive diagnostic solutions, the widening application of molecular diagnostics in the field of oncology, an aging global population and the correspondingly increasing burden of disease, a rise in demand for companion diagnostics, and escalated investment from biopharmaceutical firms. Key market trends to watch for in this period include a shift towards recombinant and synthetic raw materials, the integration of multiplex assays that necessitate specialized materials, an uptick in demand for lyophilized and ready-to-use reagent formats, and the manufacture of raw materials designed to fit microfluidic and lab-on-a-chip systems.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp
What Underlying Factors Are Supporting The IVD Raw Materials Market Growth?
The anticipated growth of the IVD raw materials market is largely due to the rising incidence of infectious diseases. Infectious diseases, caused by damaging microbes that can be transmitted from person to person or organism to organism, are becoming more prevalent due to expanding urbanization. This urban growth contributes to the spread of these diseases by heightening population density and placing additional pressure on sanitation and healthcare systems. IVD raw materials are essential in the fight against infectious diseases, as they facilitate the creation of precise diagnostic tests for early detection and efficient disease treatment. For example, a 2023 report from the Statens Serum Institut, a medical laboratory in Denmark, revealed that there were 146 chronic hepatitis C cases in 2021, 72% (105 cases) of which were men, and by 2022, this figure had risen to 196 cases, 67% (131 cases) of which were men. This surge in infectious diseases supports the growth of the IVD raw materials market.
How Does The IVD Raw Materials Market Differ By Segment?
The ivd raw materialsmarket covered in this report is segmented –
1) By Product: Antibodies; Antigens; Enzymes; Proteins; Biological Buffers; Other Products
2) By Technology: Molecular Diagnostics; Clinical Chemistry; Immunochemistry; Other Technologies
3) By End User: Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations; Other End Users
Subsegments:
1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies
2) By Antigens: Recombinant Antigens; Native Antigens; Synthetic Antigens
3) By Enzymes: Polymerases; Reverse Transcriptases; Oxidases
4) By Proteins: Carrier Proteins; Blocking Proteins; Recombinant Proteins
5) By Biological Buffers: Tris Buffers; HEPES Buffers; Phosphate Buffers
6) By Other Products: Stabilizers; Surfactants; Preservatives
What New Opportunities Are Emerging From Trends In The IVD Raw Materials Market?
Leading firms in the IVD raw materials market are currently working to create innovative solutions, such as IVD production facilities. These efforts aim to enhance regional diagnostic abilities and promote self-sufficiency in healthcare. IVD manufacturing facilities are factories specializing in developing, manufacturing, and examining the quality of devices and equipment for disease diagnosis via lab testing of samples outside the human body. For example, in January 2024, Colexa Biosensor Limited, an Nigerian-based health tech firm, collaborated with Codix Pharma Limited, also headquartered in Nigeria, to introduce the very first in vitro diagnostics (IVD) manufacturing facility in Sub-Saharan Africa, located in Lagos. This facility primarily manufactures the onpoint blood glucose meter and strips, marking a significant step for Africa’s healthcare sector as it responds to growing diabetes rates and aims to enhance diagnostic accessibility. The facility has the capacity to produce 3.6 million packs per year, with a potential future expansion to 10.8 million packs. Its initial focus will be to meet the demands of West Africa.
Who Are The Global Leaders Steering The IVD Raw Materials Market Forward?
Major companies operating in the IVD raw materials market are F. Hoffmann-La Roche, Merck KGaA, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company (BD), Agilent Technologies, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report
Which Region Is Likely To Register The Fastest Growth In The IVD Raw Materials Market?
North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the IVD raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp
Browse Through More Reports Similar to the Global IVD Raw Materials Market 2025, By The Business Research Company
In Vitro Diagnostics Ivd Quality Control Global Market Report 2025
Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2025
Cardiac Biomarkers Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
